Related Experiment Videos
A sensitive and semi-quantitative pediatric myoclonus evaluation scale
1Children's Research Institute, Washington, DC 20010, USA.
Insights
A new scale effectively evaluates childhood myoclonus, addressing pediatric scoring challenges. This tool offers a reliable method for assessing various myoclonic disorders in children.
Area of Science:
- Neurology
- Pediatrics
- Clinical Assessment
Background:
- Evaluating childhood myoclonus is challenging due to the absence of a standardized, pediatric-specific scoring scale.
- Existing scales lack the necessary simplicity, speed, sensitivity, and age adaptability for pediatric use.
Purpose of the Study:
- To develop and validate a new, standardized scale for evaluating myoclonus in children and young adults.
- To create a tool that is simple, rapid, sensitive, semi-quantitative, and applicable across diverse pediatric age groups.
Main Methods:
- Children and young adults with various myoclonus etiologies (e.g., progressive myoclonus epilepsy, opsoclonus-myoclonus) were videotaped.
- A new scale graded spontaneous, action, and sensory-evoked myoclonus separately (severity, intensity, distribution) on a five-point system.
- Validity and reliability were assessed by three blinded, trained observers.
Main Results:
- Action myoclonus was the most frequent type, significantly exceeding spontaneous and sensory-evoked forms in frequency, intensity, and distribution.
- Statistical analysis revealed significant differences in frequency and distribution scores between myoclonus etiologies.
- The new scale demonstrated high correlations between subscores and total scores, indicating reliability.
Conclusions:
- The developed scale is flexible, adaptable for all pediatric age groups, and minimizes missing data due to non-applicability.
- The scale, combined with videotape instructions, provides a reliable and useful tool for assessing pediatric myoclonic disorders.
Abstract:
One of the difficulties in evaluating myoclonus in childhood is the lack of a standardized scale which addresses the constraints of pediatric scoring. The scale needs to be simple and rapid as well as sensitive and semi-quantitative and applicable across different ages. We videotaped children and young adults with myoclonus of various etiologies, such as progressive myoclonus epilepsy, opsoclonus-myoclonus and other acquired etiologies, and scored the videotapes using a new scale. Each clinical type of myoclonus (spontaneous, action and sensory-evoked myoclonus) was graded separately on a five-point scale for severity, intensity and distribution. Data were evaluated as separate scores and also combined for a total score. Validity and reliability were tested using a judge panel of three blinded, trained observers. Action myoclonus was the predominant form of myoclonus in our patients, and was significantly greater than spontaneous and sensory-evoked myoclonus in frequency, intensity and distribution. Separate statistical analysis performed for progressive myoclonus epilepsy and for opsoclonus-myoclonus showed the same pattern. Total scores between etiologies of myoclonus for frequency and distribution categories were significantly different. Subscores and total scores were highly correlated. We found the new scale to be flexible and adaptable for children and there were few missing values due to non-applicability of a scale item. It was useful for all pediatric age groups. The scale and videotape instructions provide a reliable tool for use in pediatric myoclonic disorders.